Purple Biotech Ltd. (PPBT)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.33
-0.08 (-2.35%)
At close: Jan 29, 2025, 3:59 PM
3.36
0.90%
After-hours Jan 29, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
PE Ratio | -1.02K | -1.21 | -3.68 | -1.6 | -2.44 | -1.88 | -1.74 | -1.49 | -0.71 | -0.33 | -1.88 |
PS Ratio | 103.25 | n/a | n/a | 44.82 | 14.27 | 9.79 | 213.72 | n/a | n/a | n/a | n/a |
PB Ratio | 0.59 | 0.56 | 1.04 | 0.56 | 1.37 | 0.93 | 2.92 | 1.35 | 0.32 | 2.26 | -5.21 |
P/FCF Ratio | -1.01 | -1.54 | -4.45 | -3.66 | -2.55 | -1.15 | -2.47 | -2.88 | -0.9 | -0.39 | -9.63 |
P/OCF Ratio | -1.01 | -1.57 | -4.48 | -3.71 | -2.56 | -1.15 | -2.48 | -2.88 | -0.9 | -0.39 | -9.63 |
OCF/S Ratio | -101.76 | n/a | n/a | -12.09 | -5.58 | -8.48 | -86.27 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | n/a | n/a | n/a | n/a | 0.38 | -0.95 |
Quick Ratio | 2.20 | 4.71 | 11.41 | 19.14 | 2.76 | 2.33 | 1.96 | 17.84 | 9.12 | 2.21 | 0.28 |
Current Ratio | 2.20 | 4.71 | 11.41 | 19.14 | 2.34 | 2.57 | 1.96 | 11.70 | 9.02 | 1.78 | 0.25 |
Asset Turnover | 0.00 | n/a | n/a | 0.01 | 0.07 | 0.07 | 0.01 | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -179.39 | -84.59 | 206.75 | -39.54 | -13.59 | -458.96 | -1.20K | -1.36K | -246.71 | -53.19 |
Return on Equity (ROE) | -0.00 | -0.46 | -0.28 | -0.35 | -0.56 | -0.49 | -1.68 | -0.91 | -0.45 | -6.79 | 2.78 |
Return on Assets (ROA) | -0.00 | -0.4 | -0.26 | -0.33 | -0.4 | -0.35 | -0.87 | -0.81 | -0.39 | -2.99 | -8.45 |
Return on Capital (ROIC) | 0.60 | -0.48 | -0.27 | 0.16 | -0.64 | -0.69 | -1.18 | -0.53 | -0.42 | -6.7 | 2.70 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.11 | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.08 | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 99.99% | 99.99% | 100.00% | 100.00% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | -2.80K% | -585% | -520% | -12.27K% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | -2.81K% | -589.3% | -556.9% | -13.01K% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | 1.26K% | -715.6% | -782.6% | -11.93K% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | 1.86K% | 4.75K% | -1.22K% | -559.2% | -849.6% | -958.93% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | 2.36K% | 5.47K% | -2.84K% | -613.7% | -555.3% | -1.43K% | n/a | n/a | n/a | n/a |